-
-
-
-
-
-
-
Inspire Medical Systems (INSP) Tops Q2 EPS by 38c, Beats on Revenue; Offers FY26 Revenue Guidance
-
-
-
-
-
-
-
BofA Securities Downgrades Inspire Medical Systems (INSP) to Underperform
-
-
-
-
-
-
-
Inspire Medical Systems (INSP) PT Lowered to $70 at Stifel Amid Slower Growth
-
-
-
-
-
-
-
Inspire Medical Systems (INSP) Strength Tied to CMS Code
-
-
-
-
-
-
-
Nephron Downgrades Inspire Medical Systems (INSP) to Hold
-
-
-
-
-
-
-
Truist Securities Downgrades Inspire Medical Systems (INSP) to Hold
-
-
-
-
-
-
-
Stifel weighs in on Inspire Medical Systems (INSP) weakness
-
468,189 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

